Mounjaro®
Starting from £179.99/mo
Start journey Learn moreIf you've typed "Wegovy offer" into a search engine, you're probably weighing up cost, trying to find a deal, or wondering whether there's a cheaper way in. The honest answer: Wegovy is a prescription-only medicine, and legitimate UK suppliers cannot discount or promote it the way a retailer might run a sale. What differs between providers is what's genuinely included in the price — and that matters more than a headline figure. This page explains what to look for, what to be cautious about, and how a clinically sound route compares to chasing a bargain.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The decision most people are actually trying to make isn't "which offer", it's "which provider can I trust, and is the price fair?" Start with the legal frame. Wegovy contains semaglutide and is licensed in the UK for weight management; it is a Prescription-Only Medicine, which means UK law prohibits advertising it to you as a consumer in the way brands promote shampoo or gym memberships. A provider cannot lawfully run a voucher code, a flash sale or a promotional offer on the medicine itself.
So when you see something marketed as a Wegovy offer circulating across UK sites, it's worth asking what's being discounted. If the price is dramatically below what other regulated pharmacies charge, the risk is that clinical review has been cut short, the supply chain isn't verified, or (in the worst cases) the product isn't genuine at all. The MHRA has seized large volumes of fake weight-loss pens from online sellers, and some counterfeit products have contained entirely wrong substances. You can check whether any online pharmacy is legitimate using the GPhC's public register before placing an order.
Price is relevant, of course. But for a medicine that requires clinical oversight, the right question isn't "what's the lowest price?", it's "what does this price include, and who is reviewing my prescription?"
Across legitimate UK providers, the cost of Wegovy treatment at private clinics and pharmacies typically reflects several things bundled together: the prescription itself, the clinical review by a registered prescriber, the medicine, and some form of follow-up or aftercare. Providers vary in how transparently they present these components. Some headline prices look competitive until you add a separate consultation fee, a delivery charge, or an admin cost for the prescription.
It's worth reading the full breakdown of Wegovy pricing in the UK before committing to any provider, because the components matter as much as the total. A price that includes ID verification, prescriber review, ongoing clinical support and tracked delivery is a different product from one that posts a pen with no follow-up. At nume, there is one price that covers the consultation, prescription, medicine, and free next-working-day delivery, no subscription, no hidden extras, and a prescriber reviews every order before dispatch.
For a broader look at the treatment and whether it might suit your situation, the Wegovy overview covers the licence, how semaglutide works, and what to expect from the titration schedule.
Before price becomes relevant, the first question is clinical suitability. Wegovy is licensed for adults with a BMI of 30 or above, or 27 or above alongside at least one weight-related condition such as high blood pressure, raised cholesterol or type 2 diabetes. Lower thresholds apply for some ethnic backgrounds under UK guidance. But BMI alone doesn't determine approval, a prescriber looks at the full picture, including any medications you're already taking and your medical history.
NICE's appraisal of semaglutide for weight management sets out the conditions under which it is recommended on the NHS, which are more restrictive than the licensed criteria and typically involve specialist weight management services. NICE technology appraisal TA875 is the reference document if you want the detail. Private treatment through a regulated pharmacy sits alongside the NHS route, not instead of it, it's a faster path for people who meet the clinical criteria but aren't waiting for an NHS referral.
One thing our prescribers hear fairly often: people who've read about semaglutide, feel certain it's right for them, and are frustrated that accessing it takes effort. That frustration is understandable. It's a reflection of how limited NHS availability has been, not a flaw in the medicine. A proper consultation is the step that separates a treatment that's safe for you from one that isn't, and it's the part no discount should remove.
Searches for Wegovy offers sometimes surface Ozempic alongside it, presented as equivalent or even cheaper. They both contain semaglutide. They are not the same product in a UK regulatory sense. Ozempic is licensed for type 2 diabetes management, not for weight loss, and prescribing it for weight management in the UK is off-label. Wegovy carries the specific weight-management licence. The differences between Wegovy and Ozempic are worth understanding clearly before making any decision.
Similarly, semaglutide is now available as a daily tablet, Wegovy tablets, approved by the MHRA in June 2026 as the first oral GLP-1 medicine licensed for weight management in the UK. If injections are a barrier for you, semaglutide in both its forms is worth reading about. The injection and tablet have different titration schedules and slightly different evidence bases; which suits you is a clinical call, not a product preference. If you have come across a Wegovy special offer that seems to sidestep this clinical step entirely, that is a reason to look more carefully at what is actually being sold. An offer on the wrong form of treatment is no offer at all.
If you'd like to understand whether you're eligible and what treatment through a GPhC-registered pharmacy looks like in practice, you can find more on our clinical team and service or go straight to a free consultation.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.